Dasatinib overcomes stroma-based resistance to the FLT3 inhibitor quizartinib using multiple mechanisms

Authors: Ami B. Patel, Anthony D. Pomicter, Dongqing Yan, Anna M. Eiring, Orlando Antelope, Jonathan A. Schumacher, Todd W. Kelley, Srinivas K. Tantravahi, Tibor J. Kovacsovics, Paul J. Shami, Thomas O’Hare, Michael W. Deininger

Published: 2020-05-14

DOI: 10.1038/s41375-020-0858-1

Source: Full article

---

Abstract

No abstract found.